Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomasZhensheng Liu, Barbara Savoldo, Helen Huls, et al.
The Journal of Clinical Investigation|June 14, 2016
Glycolysis determines dichotomous regulation of T cell subsets in hypoxiaYang Xu, Arindam Chaudhury, Ming Zhang, et al.
Cancer Immunology Research|November 14, 2019
A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell ReceptorElisa Landoni, Christof C Smith, Giovanni Fucá, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2011
Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytesSujatha Muralidharan, Patrick J Hanley, Enli Liu, et al.
Blood|February 17, 2005
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosisGianpietro Dotti, Barbara Savoldo, Martin Pule, et al.
Nature Cancer|November 8, 2021
Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid TumorsKoichi Hirabayashi, Hongwei Du, Yang Xu, et al.
Journal for Immunotherapy of Cancer|January 13, 2022
Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancerLoïc Reppel, Ourania Tsahouridis, Jason Akulian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2011
Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor eliminationLeslie E Huye, Yozo Nakazawa, Mayuri P Patel, et al.
Blood|July 2, 2008
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemiaConcetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2021
Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid LeukemiaEben I Lichtman, Hongwei Du, Peishun Shou, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomasZhensheng Liu, Barbara Savoldo, Helen Huls, et al.
The Journal of Clinical Investigation|June 14, 2016
Glycolysis determines dichotomous regulation of T cell subsets in hypoxiaYang Xu, Arindam Chaudhury, Ming Zhang, et al.
Cancer Immunology Research|November 14, 2019
A High-Avidity T-cell Receptor Redirects Natural Killer T-cell Specificity and Outcompetes the Endogenous Invariant T-cell ReceptorElisa Landoni, Christof C Smith, Giovanni Fucá, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2011
Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytesSujatha Muralidharan, Patrick J Hanley, Enli Liu, et al.
Blood|February 17, 2005
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosisGianpietro Dotti, Barbara Savoldo, Martin Pule, et al.
Nature Cancer|November 8, 2021
Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid TumorsKoichi Hirabayashi, Hongwei Du, Yang Xu, et al.
Journal for Immunotherapy of Cancer|January 13, 2022
Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancerLoïc Reppel, Ourania Tsahouridis, Jason Akulian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2011
Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor eliminationLeslie E Huye, Yozo Nakazawa, Mayuri P Patel, et al.
Blood|July 2, 2008
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemiaConcetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2021
Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid LeukemiaEben I Lichtman, Hongwei Du, Peishun Shou, et al.
Pageof 16